Dr.Lal PathLabs IPO Details

Bookbuilding IPO | ₹632 Cr | Listed at BSE, NSE | Tue, Dec 8, 2015 - Thu, Dec 10, 2015

Dr.Lal PathLabs IPO Logo

Dr.Lal PathLabs IPO is a book build issue of ₹631.91 crores. The issue is entirely an offer for sale of 1.16 crore shares of ₹631.91 crore.

Dr.Lal PathLabs IPO bidding started from Dec 8, 2015 and ended on Dec 10, 2015. The shares got listed on BSE, NSE on Dec 23, 2015.

Dr.Lal PathLabs IPO price band is set at ₹550 per share. The lot size for an application is 20. The minimum amount of investment required by an retail is ₹11,000 (20 shares) (based on upper price). The lot size investment for sNII is 19 lots (380 shares), amounting to ₹2,09,000, and for bNII, it is 91 lots (1,820 shares), amounting to ₹10,01,000.

Citigroup Global Markets India Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.

Refer to Dr.Lal PathLabs IPO RHP for detailed Information.

IPO Open

Tue, Dec 8, 2015

IPO Close

Thu, Dec 10, 2015

Issue Price

₹550 per share

Market Cap (Pre-IPO)

₹4,545.46 Cr

IPO Details

IPO Date8 to 10 Dec, 2015
Listed onWed, Dec 23, 2015
Face Value10 per share
Price Band₹540 to ₹550
Issue Price₹550 per share
Lot Size20 Shares
Sale TypeOFS only
Issue TypeBookbuilding IPO
Listing AtBSE, NSE
Retail DiscountRs 15.00 per share

Total Issue Size1,16,00,000 shares
(agg. up to ₹632 Cr)
Offer for Sale1,16,00,000 shares of ₹10
(agg. up to ₹632 Cr)
Share Holding Pre Issue8,26,44,757 shares
Share Holding Post Issue8,26,44,757 shares
BSE Script Code / NSE Symbol539524 / LALPATHLAB
ISININE600L01024

IPO Timetable

Issue Reservation

Dr.Lal PathLabs IPO comprises a total issue size of 1,16,00,000 shares. Out of which, 58,00,000 (50.00%) are allocated to QIB, 17,40,000 (15.00%) allocated to NII 40,60,000 (35.00%) allocated to RII.

Investor Category Shares Offered % of Total Issue Max Allottees
QIB Shares Offered 58,00,00050.00%NA
  − Anchor Investor Shares Offered 34,80,00030.00%NA
  − QIB (Ex. Anchor) Shares Offered 23,20,00020.00%NA
NII (HNI) Shares Offered 17,40,00015.00%NA
Retail Shares Offered 40,60,00035.00%2,03,000
Total Shares Offered 1,16,00,000100.00%

IPO Lot Size

Investors can bid for a minimum of 20 shares and in multiples thereof. 

Application Lots Shares Amount
Retail (Min) 1 20 ₹11,000
Retail (Max) 18 360 ₹1,98,000
S-HNI (Min) 19 380 ₹2,09,000
S-HNI (Max) 90 1,800 ₹9,90,000
B-HNI (Min) 91 1,820 ₹10,01,000
IPO Subscription Details

About Dr.Lal PathLabs Ltd.

Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services in India. Through its nationwide network, company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.
Company has built a national network consisting of its National Reference Laboratory in New Delhi, 163 other clinical laboratories, 1,340 patient service centers and over 5,000 pickup points as of March 31, 2015.
Company's customers include individual patients, hospitals and other healthcare providers and corporate customers.

Highlights:

1. Company offers 3,368 diagnostic and related healthcare tests.

2. Company collected 21.8 million samples from 9.9 million patients in FY 2015.

3. Company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry.

4. Its centralized information technology platform fully integrates to it network and is scalable.

Company Financials ()

Period Ended
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 To achieve the benefits of listing the Equity Shares on the Stock Exchanges

Key Performance Indicator (KPI)

KPI
RoNW27.85
Pre IPOPost IPO
Promoter Holding63.67%58.7%
Market Cap4,545.46 Cr.
The Promoters of the company are:
1. Dr. Arvind Lal;
2. Dr. Vandana Lal; and
3. Eskay House

IPO Review

[Dilip Davda]
As this is the first company under consumer healthcare diagnosis services sector having established brand and has no listed peers to compare with, it may enjoy the benefit of first mover of the sector and hence may attract fancy of investors. Although it being an expensive offer, moderate investment for short to medium term may be considered.
Read detail review...

Dr.Lal PathLabs IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers1000
Members0000

Dr Lal PathLabs IPO Subscription Status (Bidding Detail)

The Dr Lal PathLabs IPO is subscribed 33.41 times on December 10, 2015 11:15:00 PM (Day 3). The public issue subscribed 4.24 times in the retail category, 63.56 times in the QIB category, and 61.28 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)Shares OfferedShares bid for
QIB63.5623,20,000
NII61.2817,40,000
Retail4.2440,60,000
Total33.4181,20,000

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Fees of the BRLMs, underwriting commission, brokerage and selling commission, Commission and processing fees to the SCSBs for processing Bid cum Application Forms procured by Syndicate/Sub Syndicate and submitted to SCSBs, Brokerage and selling commission for Registered Brokers and fees payable to Bankers to the Offer 25.64
2 Offer related advertisements and marketing expenses, printing and stationery, distribution, postage etc. 7.20
3 Fees to the Registrar to the Offer 1.06
4 Listing fees and other regulatory expenses 1.09
5 Other expenses (legal advisors and other advisors etc.) 8.71

Listing Day Trading Information

Price DetailsBSENSE
Final Issue Price550.00550.00
Open717.00720.00
Low715.50711.15
High842.40843.70
Last Trade824.15825.00

Check IPO Performance…

IPO Registrar

MUFG Intime India Pvt.Ltd.

Contact Details

Dr.Lal PathLabs Ltd. Address
Eskay House 54,
Hanuman Road,
New Delhi 110 001, India
New Delhi, New Delhi
Open an Instant Account with Zerodha

IPO FAQs

Dr.Lal PathLabs IPO is a main-board IPO of 1,16,00,000 equity shares of the face value of ₹10 aggregating up to ₹632 Crores. The issue is priced at ₹550 per share. The minimum order quantity is 20.

The IPO opens on Tue, Dec 8, 2015, and closes on Thu, Dec 10, 2015.

MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Dr.Lal PathLabs IPO using UPI as a payment gateway. Zerodha customers can apply in Dr.Lal PathLabs IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Dr.Lal PathLabs IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Dr.Lal PathLabs IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Dr.Lal PathLabs IPO opens on Tue, Dec 8, 2015 and closes on Thu, Dec 10, 2015.

Dr.Lal PathLabs IPO lot size is 20, and the minimum amount required for application is ₹11,000.

You can apply in Dr.Lal PathLabs IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Dr.Lal PathLabs IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Dr.Lal PathLabs IPO allotment status.

The Dr.Lal PathLabs IPO listing date is on Wed, Dec 23, 2015.

Compare: